FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

Note to Correspondents

FDA Public Meeting on Obesity

Date and Time: October 23, 2003 from 9:00 a.m. to 5:00 p.m.
Place: Warren Grant Magnuson Clinical Center, Masur Auditorium, (Bldg. 10) National Institutes of Health, 9000 Rockville Pike, Bethesda, Md.
Register by October 17, 2003

The Food and Drug Administration will convene a public meeting to discuss issues within FDA’s jurisdiction related to obesity and nutrition. The purpose of the meeting is to discuss FDA’s role and responsibility in addressing the public health problem of obesity, promoting better consumer dietary and lifestyle choices that have the potential to improve the health and well-being of Americans, and how best to build a framework for messages to consumers about reducing obesity and achieving better nutrition.

The public meeting will address the following questions:

1. What is the available evidence on the effectiveness of various education campaigns to reduce obesity?
2. What are the top priorities for nutrition research to reduce obesity in children?
3. What is the available evidence that FDA can look to in order to guide rational, effective public efforts to prevent and treat obesity by behavioral or medical interventions, or combinations of both?
4. Are there changes needed to food labeling that could result in the development of healthier, lower calorie foods by industry and the selection of healthier, lower calorie foods by consumers?
5. What opportunities exist for the development of healthier foods/diets and what research might best support the development of healthier foods?
6. Based on the scientific foundation available today, what are the most important things that FDA could do that would make a significant difference in efforts to address the problem of overweight and obesity?

The Federal Register Notice is available at http://www.fda.gov/oc/opacom/hottopics/obesity.html

Contacts
Participants can register online:http://www.fda.gov/oc/opacom/hottopics/obesity.html
or via email:
Registration@ora.fda.gov

For further information about registration or oral presentations:
Patricia A. Alexander, 301-827-6328;
Registration@ora.fda.gov, Fax: 301-443-2143.

General information about the meeting:
Brian Somers, 301-436-1692
brian.somers@cfsan.fda.gov
.
Submit comments to the Docket:
Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Room 1061, Rockville, MD 20852; Docket number 2003N-0338 or via email: FDADockets@oc.fda.gov or online: http:www.fda.gov/oc/opacom/hottopics/obesity.html

Deadline for Registration and Requests for oral presentations:
October 17, 2003

####

Media Contacts   |   FDA News Page
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility

FDA Website Management Staff